Abstract

背景与目的肺癌严重威胁人类生存健康,有效的肿瘤标志物可以辅助诊断、判断预后和指导治疗。本研究旨在检测非小细胞肺癌患者肿瘤组织和血浆中烯醇化酶1(alpha-enolase, ENO1)蛋白水平,初步探讨ENO1作为肺癌相关蛋白标志物的可能性。方法采用Western blot方法检测16例肺鳞癌患者的肿瘤组织及其配对正常肺组织中ENO1蛋白水平。采用双抗体夹心酶联免疫吸附分析(enzyme-linked immunosorbent assay, ELISA)测定42例健康体检者、34例肺部良性疾病患者和84例非小细胞肺癌患者三组人群血浆中ENO1蛋白水平。结果在87.5%(14/16)的肺鳞癌患者肿瘤组织中ENO1蛋白表达量高于其配对正常肺组织;非小细胞肺癌患者血浆中ENO1蛋白水平高于健康体检者(P=0.031)和肺部良性疾病者(P=0.019),且ENO1蛋白在肺腺癌患者血浆中的水平高于肺鳞癌患者(P=0.023)。结论非小细胞肺癌肿瘤组织和血浆中ENO1蛋白水平升高,提示ENO1可作为潜在的非小细胞肺癌相关血浆蛋白标志物。

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.